Form D · Biotechnology
BIND Biosciences, Inc
Cambridge, MA · CIK 0001385228
Offering snapshot reported Feb 8, 2013 · SEC filing
- Reported sold
- $8.7M Offering amount: $20.3M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 25, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 8, 2013 | Initial | $8,697,684 | No comparison | 20 | SEC filing |
| Nov 22, 2011 | Initial | $25,547,174 | No comparison | 21 | SEC filing |
| Oct 13, 2011 | Initial | $4,750,000 | No comparison | 5 | SEC filing |
| Jun 29, 2010 | Initial | $12,420,952 | No comparison | 18 | SEC filing |
| Dec 12, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-191591
Amounts sold includes amounts received from foreign investors. Amount remaining to be sold may be sold at a second tranche closing.
Source: Form D, filed Feb 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Noubar Afeyan | Director |
| Paul Burgess | Executive |
| Omid C. Farokhzad | Director |
| Andrea Franz | Executive |
| Andrew Hirsch | Executive |
| Jeffrey Hrkach | Executive |
| Peter Barton Hutt | Director |
| Daniel Koerwer | Executive |
| Robert S Langer | Director |
| Robert Langer, Jr. | Director |
| Daniel S. Lynch | Director |
| Scott Minick | Director, Executive |
| Amir H. Nashat | Director |
| Edward Schnipper | Executive |
| Ed Schnipper | Executive |
| Yuriy Udaltsov | Director |
| James Wright | Executive |
| Jim Wright | Executive |
| Stephen Zale | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
325 Vassar Street
Cambridge, MA, 02139
Cambridge, MA, 02139